Business Description
Transgene SA
NAICS : 541720
ISIN : FR0005175080
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.46 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -1.9 | |||||
Beneish M-Score | -1.68 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.7 | |||||
3-Year EBITDA Growth Rate | -6.9 | |||||
3-Year EPS without NRI Growth Rate | -1.6 | |||||
3-Year FCF Growth Rate | -1.8 | |||||
3-Year Book Growth Rate | -36.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.27 | |||||
9-Day RSI | 58.16 | |||||
14-Day RSI | 56.75 | |||||
6-1 Month Momentum % | -17.57 | |||||
12-1 Month Momentum % | -29.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.79 | |||||
Quick Ratio | 1.79 | |||||
Cash Ratio | 1.56 | |||||
Days Sales Outstanding | 495.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | 0.94 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -2421.88 | |||||
Net Margin % | -1885.81 | |||||
FCF Margin % | -3160.22 | |||||
ROE % | -88.82 | |||||
ROA % | -41.55 | |||||
ROIC % | -95.2 | |||||
ROC (Joel Greenblatt) % | -153.49 | |||||
ROCE % | -52.82 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 112.33 | |||||
PB Ratio | 8.7 | |||||
Price-to-Tangible-Book | 8.79 | |||||
EV-to-EBIT | -5.48 | |||||
EV-to-EBITDA | -5.9 | |||||
EV-to-Revenue | 102.65 | |||||
EV-to-FCF | -3.25 | |||||
Price-to-Median-PS-Value | 1.61 | |||||
Earnings Yield (Greenblatt) % | -18.25 | |||||
FCF Yield % | -27.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Transgene SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.184 | ||
EPS (TTM) (€) | -0.22 | ||
Beta | 0.78 | ||
Volatility % | 27.51 | ||
14-Day RSI | 56.75 | ||
14-Day ATR (€) | 0.034383 | ||
20-Day SMA (€) | 1.3111 | ||
12-1 Month Momentum % | -29.32 | ||
52-Week Range (€) | 1.008 - 2.15 | ||
Shares Outstanding (Mil) | 100.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Transgene SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Transgene SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Transgene SA Frequently Asked Questions
What is Transgene SA(FRA:TGNA)'s stock price today?
When is next earnings date of Transgene SA(FRA:TGNA)?
Does Transgene SA(FRA:TGNA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |